RESEARCH

Published September 3, 2026

5-Amino-1MQ Research Guide 2026: NNMT Inhibition, NAD+ Pathways & Purity

Compliance notice: This article is for laboratory research use only. It is not medical advice, not for human consumption, not for veterinary use, and is not intended to diagnose, treat, cure, or prevent any disease.

5-Amino-1MQ is not a peptide. It is a small-molecule research compound studied as an inhibitor of nicotinamide N-methyltransferase, or NNMT. That distinction matters because the mechanism is metabolic rather than receptor-peptide signaling, and the questions researchers ask about it are different from the questions they ask about a typical peptide vial. In plain terms, the compound is studied for how it may influence nicotinamide use, methyl donor demand, and downstream NAD+ biology.

What 5-Amino-1MQ Is

NNMT catalyzes the methylation of nicotinamide to 1-methylnicotinamide, using S-adenosyl methionine as the methyl donor. Inhibition of NNMT is therefore interesting to researchers because it may alter both nicotinamide handling and cellular methyl flux. The published preclinical literature on 5-Amino-1MQ frames it as a tool compound for studying this pathway, not as a finished therapeutic product.

That mechanism is why 5-Amino-1MQ shows up in discussions about energy balance, adipose biology, and NAD+ salvage. It sits upstream of a lot of the language people use casually online, but the actual research question is narrower: what happens when NNMT activity is reduced in a controlled model?

What the Preclinical Data Suggests

The best-known studies are preclinical. In adipocyte and diet-induced obesity models, NNMT inhibition has been associated with reductions in weight gain and adiposity, along with changes in metabolic markers tied to the nicotinamide pathway. Those findings are useful because they identify a biological direction, but they do not establish a human outcome.

One reason the compound attracts attention is that it acts on a shared metabolic bottleneck rather than a single surface receptor. That makes it conceptually interesting for energy metabolism research, but it also means interpretation has to stay disciplined. A change in body composition in a mouse model does not automatically translate to a clinical effect in humans.

Why Researchers Care About NNMT

NNMT is abundant in metabolic tissues and has been studied in the context of obesity, insulin sensitivity, and cellular methylation status. Because nicotinamide is part of the NAD+ salvage pathway, any compound that shifts nicotinamide handling gets attention from researchers interested in cellular energetics. 5-Amino-1MQ is one of the tools used to probe that relationship.

That makes the compound relevant in a wider research conversation around metabolic flexibility. It is not a generic fat-loss ingredient. It is a pathway probe, and that is the correct way to think about it.

Handling, Stability, and Documentation

Small-molecule handling is simpler than peptide handling, but the same documentation discipline still applies. Record the lot number, supplier, storage date, and any solubility notes directly in the study log. Keep the vial sealed, protected from moisture and heat, and follow the supplier's storage guidance rather than assuming every small molecule behaves the same way.

If the material is being used for a controlled experiment, the certificate of analysis matters as much here as it does for any peptide. Confirm identity, purity, and lot match before the compound is added to a protocol. If the COA cannot be matched to the vial in hand, the document does not support the experiment.

What to Check Before You Buy

• Identity confirmation on the COA.

• Purity method and batch-specific lot match.

• Packaging that protects from moisture and light.

• Clear storage instructions from the supplier.

• Documentation you can keep with your study record.

Research FAQ

Is 5-Amino-1MQ a peptide? No. It is a small molecule studied as an NNMT inhibitor.

What is NNMT? Nicotinamide N-methyltransferase is an enzyme involved in nicotinamide methylation and metabolic regulation.

Does the published evidence prove human weight-loss effects? No. The work I found is preclinical, so that claim would go beyond the data.

Why do researchers care about NAD+ in this context? Because NNMT sits close to nicotinamide handling, which is part of NAD+ salvage biology.

Source Research-Grade 5-Amino-1MQ

For lot-matched documentation and current catalog availability, see 5-Amino-1MQ 10mg and the lab testing / COA page. If you need a certificate for a specific lot before ordering, contact Precision Labs. Research use only; not for human consumption.